PMID: 15230283Jul 3, 2004Paper

Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus

Lupus
Paul J Utz

Abstract

Validated biomarkers and surrogate markers are badly needed for monitoring patients with systemic lupus erythematosus (SLE), both for routine clinical care and for clinical trials research. SLE is difficult to study in clinical trials, in part because the disease is so heterogeneous. Very few useful markers have been identified, and even those that historically have been thought to be valid have been recently questioned. This report will focus on the use of emerging multiplexed assay formats that enable analysis of hundreds or even thousands of analytes simultaneously. Their potential and pitfalls for monitoring patients with SLE, particularly those enrolled in clinical trials testing novel therapeutics, will be discussed.

References

Apr 1, 1995·Seminars in Arthritis and Rheumatism·C A von Mühlen, E M Tan
Oct 31, 1998·Immunological Reviews·J A James, J B Harley
Apr 22, 1999·Immunology Today·G C Tsokos, S N Liossis
Aug 19, 2000·Electrophoresis·T O JoosH Hämmerle
Dec 20, 2000·The Journal of Clinical Investigation·A GrolleauB Richardson
Apr 6, 2001·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·S N LiossisP P Sfikakis
Feb 1, 2002·Nature Biotechnology·Omar D Perez, Garry P Nolan
Feb 28, 2002·Journal of Immunological Methods·Sun W TamKrishnanand D Kumble
Mar 5, 2002·Nature Medicine·William H RobinsonPaul J Utz
Mar 14, 2002·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Violeta RusCharles S Via
Apr 9, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zivana TezakLauren M Pachman
Apr 16, 2002·Arthritis and Rheumatism·William H RobinsonPaul J Utz
Jun 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kevin MaasThomas M Aune
Jul 18, 2002·Annals of the New York Academy of Sciences·Gary M Kammer
Jul 23, 2002·Nature Biotechnology·J Manuel PerezRalph Weissleder
Sep 5, 2002·Nature Reviews. Drug Discovery·Emanuel F PetricoinLance A Liotta
Sep 12, 2002·Arthritis Research·Wolfgang HueberWilliam H Robinson
Feb 27, 2003·Proceedings of the National Academy of Sciences of the United States of America·Emily C BaechlerTimothy W Behrens
Mar 19, 2003·The Journal of Experimental Medicine·Lynda BennettVirginia Pascual
May 10, 2003·Trends in Immunology·George C TsokosYuang-Taung Juang
May 15, 2003·Cytotherapy·S A Ghanekar, H T Maecker
Aug 12, 2003·Nature Biotechnology·William H RobinsonLawrence Steinman
Aug 23, 2003·Arthritis Research & Therapy·Donna L Thibault, Paul J Utz
Sep 2, 2003·Nature Biotechnology·Eli E Sercarz
Oct 7, 2003·Oncogene·Giuseppe RussoAntonio Giordano
Oct 17, 2003·The New England Journal of Medicine·Melissa R ArbuckleJohn B Harley
Nov 5, 2003·Proteomics·William H RobinsonPaul J Utz
Dec 19, 2003·Arthritis Research & Therapy·Mary K Crow, Jay Wohlgemuth
Jan 31, 2004·Gynecologic Oncology·Y-M ChanL C Wong
May 13, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·P-Y Chan-HuiS Singh

❮ Previous
Next ❯

Citations

Jun 22, 2011·Nature Reviews. Rheumatology·Marina Sirota, Atul J Butte
Aug 12, 2005·Current Opinion in Rheumatology·Chau-Ching LiuJoseph M Ahearn
Jan 3, 2014·International Journal of Rheumatic Diseases·Mahdieh ShojaaSedigheh Livani
Dec 22, 2009·Clinical Chemistry·Qin FuJennifer E Van Eyk
May 8, 2014·Journal of Immunology Research·Sonal Mehra, Marvin J Fritzler
Mar 28, 2008·Expert Review of Molecular Diagnostics·Chang-Hee Suh, Hyoun-Ah Kim
Mar 20, 2012·Translational Research : the Journal of Laboratory and Clinical Medicine·Joseph M AhearnSusan Manzi
Jul 14, 2009·Best Practice & Research. Clinical Rheumatology·Chau-Ching Liu, Joseph M Ahearn
Oct 9, 2007·Advances in Pediatrics·Stephen W HunsuckerMark W Duncan
Mar 26, 2005·Immunological Reviews·Paul J Utz
Feb 8, 2006·Annals of the New York Academy of Sciences·Steven M Chan, Paul J Utz
Dec 8, 2010·Proteomics. Clinical Applications·Qin FuJennifer E Van Eyk
Jan 10, 2014·International Journal of Rheumatic Diseases·Mahdieh ShojaaNeda Ranjbarpour
May 13, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Paul J Utz
Apr 29, 2006·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Marvin J FritzlerMark L Fritzler
Mar 23, 2010·Journal of American College Health : J of ACH·Jennifer P ReadKatrina Bytschkow
Jul 25, 2021·International Journal of Molecular Sciences·James Greenan-BarrettCoziana Ciurtin
Nov 21, 2020·Current Rheumatology Reviews·Rania Mohammed KishkMarwa Mohamed Fouad

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
Laura F SteelSamir M Hanash
Clinical Immunology : the Official Journal of the Clinical Immunology Society
Aaron B KantorChristopher Becker
© 2022 Meta ULC. All rights reserved